Lower limb amputations due to ischemia represent an important health care and social issue. However, there are currently no specific biomarkers able to predict the risk of amputation and postamputation complications and prognosis. We conducted a systematic review of studies investigating whether blood cell count indexes of systemic inflammation are linked to the risk and the outcome of lower limb amputations due to ischemia. Overall, in 22 studies involving 8832 patients selected for review, several blood cell count indexes, particularly the neutrophil lymphocyte ratio, showed some promise in terms of predicting amputations and general outcomes of conservative and surgical treatments, as well as postamputation complications and prognosis. However, largely due to methodological limitations, further prospective studies are required to establish the clinical utility and applicability of blood cell indexes in the routine management of patients with ischemia-related lower limb amputations.
LinCWArmstrongDGLinCH, et al. Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period. BMJ Open Diabetes Res Care. 2019;7:e000795.
2.
Ziegler-GrahamKMacKenzieEJEphraimPLTravisonTGBrookmeyerR.Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89:422-429.
3.
DillinghamTRPezzinLEMacKenzieEJ.Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95:875-883.
4.
ForouhiNWarehamN.Epidemiology of diabetes. Medicine (Abingdon). 2019;47:22-27.
5.
HardingJLPavkovMEGreggEWBurrowsNR.Trends of nontraumatic lower-extremity amputation in end-stage renal disease and diabetes: United States, 2000-2015. Diabetes Care. 2019;42:1430-1435.
6.
KerrMBarronEChadwickP, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36:995-1002.
7.
VarmaPStinemanMGDillinghamTR.Epidemiology of limb loss. Phys Med Rehabil Clin N Am. 2014;25:1-8.
8.
HirschATMurphyTPLovellMB, et al; Peripheral Arterial Disease Coalition. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation. 2007;116:2086-2094.
9.
FowkesFGRudanDRudanI, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-1340.
10.
SongPRudanDZhuY, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020-e1030.
11.
AgnelliGBelchJJFBaumgartnerIGiovasPHoffmannU.Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis. 2020;293:94-100.
12.
JonesWSPatelMRDaiD, et al. Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from US Medicare 2000-2008. J Am Coll Cardiol. 2012;60:2230-2236.
13.
HajibandehSHajibandehSHobbsNMansourM.Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: a systematic review and meta-analysis. Am J Surg. 2020;219:154-163.
14.
WangQMaJJiangZMingL.Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol. 2018;37:4-11.
15.
DongCHWangZMChenSY.Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: a systematic review and meta-analysis. Clin Biochem. 2018;52:131-136.
16.
PaliogiannisPSattaRDeligiaG, et al. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med. 2019;19:37-45.
17.
ErreGLPaliogiannisPCastagnaF, et al. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest. 2019;49:e13037.
18.
PaliogiannisPFoisAGSotgiaS, et al. The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: a systematic review and meta-analysis. Eur J Clin Invest. 2018;48:e12984.
19.
PinnaAPorcuTD’Amico-RicciG, et al. Complete blood cell count-derived inflammation biomarkers in Men with age-related macular degeneration. Ocul Immunol Inflamm. 2019;27:932-936.
20.
PaliogiannisPFoisAGSotgiaS, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018;27:170113.
21.
ZhangJZhangHYLiJShaoXYZhangCX.The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8:68837-68846.
22.
ZhengJCaiJLiH, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review. Cell Physiol Biochem. 2017;44:967-981.
23.
PaliogiannisPScognamilloFBellomoM, et al. Neutrophil to lymphocyte ratio as a predictor of thyroid papillary carcinoma. Acta Med Mediterr. 2015;31:371-375.
24.
WangYZhouYZhouKLiJCheG.Prognostic value of pre-treatment red blood cell distribution width in lung cancer: a meta-analysis. Biomarkers. 2020;25:241-247.
25.
WangPFSongSYGuoHWangTJLiuNYanCX.Prognostic role of pretreatment red blood cell distribution width in patients with cancer: a meta-analysis of 49 studies. J Cancer. 2019;10:4305-4317.
26.
PaliogiannisPZinelluAMangoniAA, et al. Red blood cell distribution width in pregnancy: a systematic review. Biochem Med (Zagreb). 2018;28:030502.
27.
PyoJSSohnJHKangG.Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets. 2016;27:722-728.
28.
VatankhahNJahangiriYLandryGJ, et al. Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing. J Vasc Surg. 2017;65:478-483.
29.
YapıcıOBerkHÖztoprakNSeymanDTahmazAMerdinA.Can ratio of neutrophil-to-lymphocyte count and erythrocyte sedimentation rate in diabetic foot infection predict osteomyelitis and/or amputation?Hematol Rep. 2017;9:6981.
30.
AltayFAKuziSAltayM, et al. Predicting diabetic foot ulcer infection using the neutrophil-to-lymphocyte ratio: a prospective study. J Wound Care. 2019;28:601-607.
31.
ArıcanGKahramanHÇÖzmeriçAİltarSAlemdaroğluKB.Monitoring the prognosis of diabetic foot ulcers: predictive value of neutrophil-to-lymphocyte ratio and red blood cell distribution width. Int J Low Extrem Wounds. Published online February 10, 2020. doi:10.1177/1534734620904819
32.
TaşoğluİSertDColakNUzunASongurMEcevitA. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost. 2014;20:645-650.
33.
LuoHYuanDYangH, et al. Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation. Clinics (Sao Paulo). 2015;70:273-277.
34.
DemirdalTSenP.The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection. Diabetes Res Clin Pract. 2018;144:118-125.
35.
KullarPWeerakoddyRWalshS.Neutrophil-lymphocyte ratio predicts graft patency following lower limb revascularisation. Acta Chir Belg. 2012;112:365-368.
36.
TaşoğluIÇiçekOFLafciG, et al. Usefulness of neutrophil/lymphocyte ratio as a predictor of amputation after embolectomy for acute limb ischemia. Ann Vasc Surg. 2014;28:606-613.
37.
ChanCPuckridgePUllahSDelaneyCSparkJI.Neutrophil-lymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia. J Vasc Surg. 2014;60:661-668.
38.
SanzJABFajardoJAGTaylorJHSoláLRMorenoMFMPuertaCV. Design of a new risk score in critical limb ischaemia: the ERICVA model. Eur J Vasc Endovasc Surg. 2016;51:90-99.
39.
González-FajardoJABrizuela-SanzJAAguirre-GervásB, et al. Prognostic significance of an elevated neutrophil-lymphocyte ratio in the amputation-free survival of patients with chronic critical limb ischemia. Ann Vasc Surg. 2014;28:999-1004.
40.
BathJSmithJBKruseRLVogelTR.Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures. J Vasc Surg. 2020;72:622-631. doi:10.1016/j.jvs.2019.10.094
41.
ChenICYuCCWuYHChaoTH.Elevated neutrophil-to-lymphocyte ratio predicts intermediate-term outcomes in patients who have advanced chronic kidney disease with peripheral artery disease receiving percutaneous transluminal angioplasty. Acta Cardiol Sin. 2016;32:532-541.
42.
Ruiz-CarmonaCVelescuACalsinaAGLElosuaRClaraA.The neutrophil to lymphocyte ratio is a prognostic biomarker of mortality among patients with acute limb ischaemia. Eur J Vasc Endovasc Surg. 2020;59:1036-1037.
43.
DincTDuzgunAPKayiliogluSIErdoganAYavuzZCoskunF.Factors affecting mortality after major nontraumatic lower extremity amputation. Int J Low Extrem Wounds. 2016;15:227-231.
44.
MetinerenHDülgeroğluTC.Comparison of the neutrophil/lymphocyte ratio and C-reactive protein levels in patients with amputation for diabetic foot ulcers. Int J Low Extrem Wounds. 2017;16:23-28.
45.
WangQLiuHSunS, et al. Neutrophil-to-lymphocyte ratio is effective prognostic indicator for post-amputation patients with critical limb ischemia. Saudi Med J. 2017;38:24-29.
46.
GocerHBuyukcerenICoskunSKeskinDDabakN.Preoperative PLR and NLR values as predictors of mortality in diabetic foot amputations. Biomed Res. 2017;28:1629-1632.
47.
Pierre-LouisWSBathJMikkilineniS, et al. Neutrophil to lymphocyte ratio as a predictor of outcomes after amputation. Ann Vasc Surg. 2019;54:84-91.
48.
SaskinHOzcanKSDuzyolCBarisOKoçoğullarıUC.Are inflammatory parameters predictors of amputation in acute arterial occlusions?Vascular. 2017;25:170-177.
49.
HuangHLJuangJJHsiehCAChouHHJangSJKoYL.Risk stratification for low extremity amputation in critical limb ischemia patients who have undergone endovascular revascularization: a survival tree analysis. Medicine (Baltimore). 2019;98:e16809.
50.
O’BrienPJCoxMWShortellCKScarboroughJE.Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures. J Am Coll Surg. 2013;216:836-842.
51.
ThomasMRStoreyRF.The role of platelets in inflammation. Thromb Haemost. 2015;114:449-458.
52.
MüllerFMutchNJSchenkWA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139:1143-1156.
53.
DucheneJvon HundelshausenP.Platelet-derived chemokines in atherosclerosis. Hamostaseologie. 2015;35:137-141.
54.
TunçezAÇetinMSÇetinEHYilmazSKorkmazAUçarFM.Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Medicine (Baltimore). 2017;96:e5986.
55.
CohenJFKorevaarDAAltmanDG, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6:e012799.
56.
TsilimigrasDIMorisDMehtaR, et al. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB (Oxford). Published online April 4, 2020. doi:10.1016/j.hpb.2020.03.011
57.
PaliogiannisPGinesuGCTandaC, et al. Inflammatory cell indexes as preoperative predictors of hospital stay in open elective thoracic surgery. ANZ J Surg. 2018;88:616-620.
58.
PutzuCCortinovisDLColoneseF, et al. Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with nivolumab. Cancer Immunol Immunother. 2018;67:1349-1353.
59.
Pacheco-BarciaVMondéjar SolísRFranceT, et al. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology. 2020;20:254-264.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
